Answers are grounded in this paper and cite their sources.
Evaluates Cu2−xSe nanocrystals as photoacoustic contrast agents, suggesting their potential for biomedical imaging.
Copper-deficient copper selenide (Cu2−xSe) nanocrystals possess strong near-infrared (NIR) absorption and efficient photothermal conversion, making them attractive candidates for photoacoustic imaging . In this study, Cu2−xSe nanocrystals with distinct morphologies were synthesized using different selenium precursors and evaluated as photoacoustic contrast agents. Se–oleylamine precursors produced predominantly disk-shaped nanocrystals with average dimensions of approximately 20 nm in diameter and 5 nm in thickness, while Se–TOP/TOPO precursors yielded smaller spherical nanocrystals. Structural characterization by transmission electron microscopy, high-resolution TEM, and selected-area electron diffraction confirmed the formation of highly crystalline copper-deficient Cu2−xSe nanocrystals with a face-centered cubic crystal structure. UV–Vis–NIR spectroscopy revealed broad optical absorption extending into the NIR region, with morphology-dependent spectral characteristics. Multispectral optoacoustic tomography demonstrated strong photoacoustic signal generation from both nanodisks and nanospheres over a broad wavelength range. In vivo studies using PEGylated Cu2−xSe nanospheres showed successful lymphatic uptake following hind paw injection and enabled visualization of the draining popliteal lymph node through spectral unmixing of nanoparticle and hemoglobin signals. These results demonstrate that Cu2−xSe nanocrystals are promising photoacoustic contrast agents for lymphatic imaging and other biomedical imaging applications.
No takes yet. Share an insight, caveat, or question.
Fuentes et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: